Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(acetylsalicylic acid)
76,319 results
  • A hybrid automated event adjudication system for clinical trials. [Journal Article]
    Clin Trials. 2023 Feb 03 [Online ahead of print]Yuan F, Bosch J, … Bangdiwala SI
  • CONCLUSIONS: The automated event adjudication system in combination with human adjudicators provides a streamlined and efficient approach to event adjudication in clinical trials. To immediately apply automated event adjudication, one can first consider the automated event adjudication system and involve human assistance for cases unconfirmed by the former.
  • Anticoagulation for Atrial Fibrillation: A Review of Current Literature and Views. [Journal Article]
    Cardiol Rev. 2022 Nov 21 [Online ahead of print]Jin C, Cui C, … Iwai S
  • Atrial fibrillation is a common supraventricular tachyarrhythmia with uncoordinated atrial activation and ineffective atrial contraction. This leads to an increased risk of atrial thrombi, most commonly in the left atrial appendage, and increased risks of embolic strokes and/or peripheral thromboembolism. It is associated with significant morbidity and mortality. To meet the concerns of thrombi a…
  • Monitoring antiplatelet therapy: where are we now? [Journal Article]
    J Cardiovasc Med (Hagerstown). 2022 Dec 15 [Online ahead of print]Marcucci R, Berteotti M, … Working Group of Thrombosis of the Italian Society of Cardiology
  • Single antiplatelet therapy represents the cornerstone of thrombosis prevention in atherosclerotic cardiovascular disease. Dual antiplatelet therapy (DAPT), consisting of aspirin plus a P2Y12 inhibitor, is the standard of care for patients with acute coronary syndrome or undergoing both coronary and peripheral percutaneous interventions. Recent data suggest the efficacy of DAPT also after minor s…
  • NHANES cross sectional study of aspirin and fractures in the elderly. [Journal Article]
    Sci Rep. 2023 Feb 01; 13(1):1879.Swed S, El-Sakka AA, … Rakab A
  • Bone fractures are a global public health concern, yet no thorough investigation of low-dose aspirin usage to prevent fractures in the elderly has been conducted. Many interventional human and animal studies have tried to detect the correct role of low-dose aspirin on fractures in elderly persons. The literature doesn't consist of a retrospective observational study that includes a large number o…
  • Dual Antiplatelet Therapy Does Not Increase Bleeding Risk in Percutaneous Gastrostomy Tube Placement: Network Meta-Analysis. [Journal Article]
    Dig Dis Sci. 2023 Jan 31 [Online ahead of print]Gangwani MK, Aziz M, … Hart B
  • CONCLUSIONS: There is no significant difference in bleeding risk between DAPT, single antiplatelet or no antiplatelet therapy on a population level. On an individual level, risk of ischemic events should be weighed against the risk of bleeding based on patient circumstances and risk profile. Our findings offer to provide additional data to make an informed decision between patients and physicians to make clinical decisions by assessing individual risks and benefits for optimal care of complex patients.
  • SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD. [Journal Article]
    Allergy Asthma Proc. 2023 Jan 01; 44(1):78-80.Tripathi SH, Corr A, … Bosso JV
  • Background: Aspirin exacerbated respiratory disease (AERD) is an inflammatory condition that consists of eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and respiratory reactions to cyclooxygenase-1 inhibitors. Aspirin therapy after aspirin desensitization (ATAD) is the most extensively studied treatment paradigm for AERD. Objective: The objective was to identify which time point o…
  • Repurposing some of the Well-Known Non-Steroid Anti-Inflammatory Drugs [Nsaids] for Cancer Treatment. [Journal Article]
    Curr Top Med Chem. 2023 Jan 30 [Online ahead of print]Sousa SM, Xavier CPR, … Palmeira A
  • Drug repurposing is a strategy used to develop new treatments based on approved or investigational drugs outside the scope of their original clinical indication. Since this approach benefits from the original toxicity data of the repurposed drugs, the drug-repurposing strategy is time-saving, and inexpensive. It has a higher success rate compared to traditional drug discovery. Several repurposing…
New Search Next